Astrotech Corp
ASTC
Market cap $12M

7.05 USD

-0.17

2.35%

At close Nov 18, 4:00 PM EST

1 day

-2.35%

5 days

-1.81%

1 month

-15.06%

3 months

-31.55%

6 months

-27.02%

Year to date

-17.64%

1 year

-5.62%

5 years

-87.09%

10 years

-98.13%

About: Astrotech Corp is a science and technology development company. The firm invents, acquires, and commercializes technological innovations sourced from internal research, universities, laboratories, and research institutions. The 1st Detect develops, manufactures, and sells chemical analyzers for use in the airport security, military, and breath analysis markets. AgLAB develops a series of mass spectrometers for use in the agriculture market.

Employees: 30

Industrials Laboratory Analytical Instruments

0

Funds holding %

of 6,704 funds

–

Analysts bullish %

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

300% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 1

67% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 3

19% more funds holding

Funds holding: 16 [Q2] → 19 (+3) [Q3]

2.13% more ownership

Funds ownership: 23.98% [Q2] → 26.1% (+2.13%) [Q3]

2% less capital invested

Capital invested by funds: $3.64M [Q2] → $3.56M (-$77.3K) [Q3]

See Fund Rankings

Research analyst outlook

We haven’t received any recent analyst ratings for ASTC.

See Analyst Rankings

Financial journalist opinion

Astrotech Reports First Quarter of Fiscal Year 2025 Financial Results

AUSTIN, Texas, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) reported its financial results for the first quarter of fiscal year 2025, which ended September 30, 2024.

Astrotech Reports First Quarter of Fiscal Year 2025 Financial Results

Astrotech Reports Fiscal Year 2024 Financial Results

AUSTIN, Texas, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) reported its financial results for the fiscal year ended June 30, 2024.

Astrotech Reports Fiscal Year 2024 Financial Results

Astrotech Reports Third Quarter of Fiscal Year 2024 Financial Results

AUSTIN, Texas, May 13, 2024 (GLOBE NEWSWIRE) -- Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) reported its financial results for the third quarter of fiscal year 2024, which ended March 31, 2024.

Astrotech Reports Third Quarter of Fiscal Year 2024 Financial Results

Astrotech Announces Listing to the GSA as an Approved United States Government Vendor

Astrotech Announces Listing to the GSA as an Approved United States Government Vendor AUSTIN, Texas, April 08, 2024 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ: ASTC) ("Astrotech" or the "Company") and its wholly owned subsidiary, 1st Detect Corporation (1st Detect), announce that 1st Detect's TRACER 1000TM is now listed in the U.S. General Services Administration (GSA) IT Schedule 70 under Contract No. GS-35F-250GA with SRI Group LLC, Special Item Number 334290.

Astrotech Announces Listing to the GSA as an Approved United States Government Vendor

Astrotech to Showcase the Tracer 1000 Trace Detector at ISC West Conference

The TRACER 1000 Narcotic and Explosives Trace Detector is a rugged mass-spectrometer capable of rapid detection of trace levels of narcotic or explosive compounds in seconds. The TRACER 1000 Narcotic and Explosives Trace Detector is a rugged mass-spectrometer capable of rapid detection of trace levels of narcotic or explosive compounds in seconds.

Astrotech to Showcase the Tracer 1000 Trace Detector at ISC West Conference

Astrotech Introduces the “Gold Standard” of Mass Spectrometry into Narcotics Detection Market with its State-of-the-Art Tracer 1000

The TRACER 1000™ is a mass spectrometry-based trace analyzer; its detection library now includes narcotics such as fentanyl, heroin, and cocaine. The TRACER 1000™ is a mass spectrometry-based trace analyzer; its detection library now includes narcotics such as fentanyl, heroin, and cocaine.

Astrotech Introduces the “Gold Standard” of Mass Spectrometry into Narcotics Detection Market with its State-of-the-Art Tracer 1000

Astrotech Reports Second Quarter Of Fiscal Year 2024 Financial Results

AUSTIN, Texas, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) reported its financial results for the second quarter of fiscal year 2024, which ended December 31, 2023.

Astrotech Reports Second Quarter Of Fiscal Year 2024 Financial Results

Astrotech Announces Exciting New Technology Application and Introduces New Subsidiary

AUSTIN, Texas, Dec. 12, 2023 (GLOBE NEWSWIRE) -- - via IBN - Astrotech Corporation (NASDAQ:ASTC) ("Astrotech" or the "Company") announces formation of a wholly owned subsidiary Pro-Control, Inc. (“Pro-Control”) and has entered into an exclusive license to use the ATi Mass Spectrometer Technology for chemical manufacturing process control applications. Pro-Control is announcing the introduction of its proprietary Pro-Control Maximum Value ProcessTM (“Pro-Control MVPTM”) and the Pro-Control-1000TM mass spectrometer designed to test, measure and increase potency, purity and weight yields in the chemical manufacturing processes, delivering value to our customers by facilitating improved yields, which we believe will lead to an overall increase in profitability.

Astrotech Announces Exciting New Technology Application and Introduces New Subsidiary

Astrotech Presents the First Process Control System for Cannabinoid Oil Distillation Systems

Astrotech's proven AgLAB Maximum Value Process™ delivers 32% average increase in revenue Astrotech's proven AgLAB Maximum Value Process™ delivers 32% average increase in revenue

Astrotech Presents the First Process Control System for Cannabinoid Oil Distillation Systems

See News Rankings

Charts implemented using Lightweight Charts™